<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00800111</url>
  </required_header>
  <id_info>
    <org_study_id>CRFA2008-01</org_study_id>
    <nct_id>NCT00800111</nct_id>
  </id_info>
  <brief_title>Study of Endothelial Keratoplasty Outcomes</brief_title>
  <official_title>Open-enrollment, Prospective Study of Endothelial Keratoplasty Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cornea Research Foundation of America</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cornea Research Foundation of America</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endothelial keratoplasty is a cornea-sparing transplant technique that replaces only the
      diseased endothelial cell layer of the patient's cornea. This technique offers many
      advantages compared with traditional full-thickness cornea transplants. Patients experience
      minimal change in glasses prescription and usually recover useful vision within weeks. Visual
      fluctuations are minimal during the healing process. The patient's cornea remains
      structurally intact and is more resistant to injury.

      Endothelial keratoplasty is undergoing rapid and widespread adoption. Between 2005 and 2007,
      the number of corneas placed by US eye banks for endothelial keratoplasty increased ten-fold
      (2007 Eye Bank Association of America Annual Report). However, the procedure is less than 10
      years old, and little is known about long term outcomes. Endothelial keratoplasty candidates
      at our center are invited to participate in an open enrollment, prospective study of the
      long-term outcomes of this procedure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Anticipated">February 2025</completion_date>
  <primary_completion_date type="Anticipated">February 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>1, 3, 6, and 12 months and annually</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endothelial cell density</measure>
    <time_frame>6 months, 12 months and annually</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraocular pressure</measure>
    <time_frame>1, 3, 6, 12 months and annually</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Manifest refraction</measure>
    <time_frame>1, 3, 6, 12 months and annually</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>corneal pachymetry</measure>
    <time_frame>1, 3, 6, 12 months and annually</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Fuchs' Endothelial Corneal Dystrophy</condition>
  <condition>Bullous Keratopathy</condition>
  <condition>Iridocorneal Endothelial Syndrome</condition>
  <condition>Posterior Polymorphous Dystrophy</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Endothelial keratoplasty procedure is performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endothelial keratoplasty</intervention_name>
    <description>Endothelial keratoplasty is surgical replacement of the corneal endothelial cell layer (the cell layer lining the inner surface of the cornea).</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>Descemet stripping endothelial keratoplasty</other_name>
    <other_name>Descemet stripping automated endothelial keratoplasty</other_name>
    <other_name>Descemet membrane endothelial keratoplasty</other_name>
    <other_name>DSEK</other_name>
    <other_name>DSAEK</other_name>
    <other_name>DMEK</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female aged 18 or older

          -  Scheduled to undergo endothelial keratoplasty

          -  Able to provide written informed consent.

        Exclusion Criteria:

          -  Age less than 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francis W Price, Jr., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cornea Research Foundation of America</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francis W Price, Jr., MD</last_name>
    <phone>317-814-2990</phone>
    <email>fprice@pricevisiongroup.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Price Vision Group</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francis W Price, Jr., MD</last_name>
    </contact>
    <investigator>
      <last_name>Francis W Price, Jr., MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.cornea.org</url>
    <description>Cornea Research Foundation of America website</description>
  </link>
  <reference>
    <citation>Vajaranant TS, Price MO, Price FW, Wilensky JT, Edward DP. Intraocular pressure measurements following Descemet stripping endothelial keratoplasty. Am J Ophthalmol. 2008 May;145(5):780-6. doi: 10.1016/j.ajo.2008.01.010. Epub 2008 Mar 10.</citation>
    <PMID>18329627</PMID>
  </reference>
  <reference>
    <citation>Allan BD, Terry MA, Price FW Jr, Price MO, Griffin NB, Claesson M. Corneal transplant rejection rate and severity after endothelial keratoplasty. Cornea. 2007 Oct;26(9):1039-42.</citation>
    <PMID>17893530</PMID>
  </reference>
  <reference>
    <citation>Price MO, Price FW Jr. Endothelial cell loss after descemet stripping with endothelial keratoplasty influencing factors and 2-year trend. Ophthalmology. 2008 May;115(5):857-65. Epub 2007 Sep 14.</citation>
    <PMID>17868873</PMID>
  </reference>
  <reference>
    <citation>Price MO, Price FW. Descemet's stripping endothelial keratoplasty. Curr Opin Ophthalmol. 2007 Jul;18(4):290-4. Review.</citation>
    <PMID>17568204</PMID>
  </reference>
  <reference>
    <citation>Price MO, Price FW Jr, Trespalacios R. Endothelial keratoplasty technique for aniridic aphakic eyes. J Cataract Refract Surg. 2007 Mar;33(3):376-9.</citation>
    <PMID>17321384</PMID>
  </reference>
  <reference>
    <citation>Price FW Jr, Price MO. Endothelial keratoplasty to restore clarity to a failed penetrating graft. Cornea. 2006 Sep;25(8):895-9.</citation>
    <PMID>17102663</PMID>
  </reference>
  <reference>
    <citation>Price MO, Price FW Jr. Descemet's stripping with endothelial keratoplasty: comparative outcomes with microkeratome-dissected and manually dissected donor tissue. Ophthalmology. 2006 Nov;113(11):1936-42. Epub 2006 Aug 28.</citation>
    <PMID>16935344</PMID>
  </reference>
  <reference>
    <citation>Price FW Jr, Price MO. Descemet's stripping with endothelial keratoplasty in 200 eyes: Early challenges and techniques to enhance donor adherence. J Cataract Refract Surg. 2006 Mar;32(3):411-8.</citation>
    <PMID>16631048</PMID>
  </reference>
  <reference>
    <citation>Price FW Jr, Price MO. Descemet's stripping with endothelial keratoplasty in 50 eyes: a refractive neutral corneal transplant. J Refract Surg. 2005 Jul-Aug;21(4):339-45.</citation>
    <PMID>16128330</PMID>
  </reference>
  <results_reference>
    <citation>Guerra FP, Anshu A, Price MO, Giebel AW, Price FW. Descemet's membrane endothelial keratoplasty: prospective study of 1-year visual outcomes, graft survival, and endothelial cell loss. Ophthalmology. 2011 Dec;118(12):2368-73. doi: 10.1016/j.ophtha.2011.06.002. Epub 2011 Aug 27.</citation>
    <PMID>21872938</PMID>
  </results_reference>
  <results_reference>
    <citation>Pereira Cda R, Guerra FP, Price FW Jr, Price MO. Descemet's membrane automated endothelial keratoplasty (DMAEK): visual outcomes and visual quality. Br J Ophthalmol. 2011 Jul;95(7):951-4. doi: 10.1136/bjo.2010.191494. Epub 2010 Dec 22.</citation>
    <PMID>21183511</PMID>
  </results_reference>
  <results_reference>
    <citation>McCauley MB, Price MO, Fairchild KM, Price DA, Price FW Jr. Prospective study of visual outcomes and endothelial survival with Descemet membrane automated endothelial keratoplasty. Cornea. 2011 Mar;30(3):315-9. doi: 10.1097/ICO.0b013e3181eeb71b.</citation>
    <PMID>21099412</PMID>
  </results_reference>
  <results_reference>
    <citation>Guerra FP, Anshu A, Price MO, Price FW. Endothelial keratoplasty: fellow eyes comparison of Descemet stripping automated endothelial keratoplasty and Descemet membrane endothelial keratoplasty. Cornea. 2011 Dec;30(12):1382-6. doi: 10.1097/ICO.0b013e31821ddd25.</citation>
    <PMID>21993468</PMID>
  </results_reference>
  <results_reference>
    <citation>Kwon RO, Price MO, Price FW Jr, Ambr√≥sio R Jr, Belin MW. Pentacam characterization of corneas with Fuchs dystrophy treated with Descemet membrane endothelial keratoplasty. J Refract Surg. 2010 Dec;26(12):972-9. doi: 10.3928/1081597X-20100212-08. Epub 2010 Feb 15.</citation>
    <PMID>20166622</PMID>
  </results_reference>
  <results_reference>
    <citation>Price MO, Giebel AW, Fairchild KM, Price FW Jr. Descemet's membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival. Ophthalmology. 2009 Dec;116(12):2361-8. doi: 10.1016/j.ophtha.2009.07.010. Epub 2009 Oct 28.</citation>
    <PMID>19875170</PMID>
  </results_reference>
  <results_reference>
    <citation>McCauley MB, Price FW Jr, Price MO. Descemet membrane automated endothelial keratoplasty: hybrid technique combining DSAEK stability with DMEK visual results. J Cataract Refract Surg. 2009 Oct;35(10):1659-64. doi: 10.1016/j.jcrs.2009.05.034.</citation>
    <PMID>19781456</PMID>
  </results_reference>
  <results_reference>
    <citation>Feng MT, Burkhart ZN, Price FW Jr, Price MO. Effect of donor preparation-to-use times on Descemet membrane endothelial keratoplasty outcomes. Cornea. 2013 Aug;32(8):1080-2. doi: 10.1097/ICO.0b013e318292a7e5.</citation>
    <PMID>23635858</PMID>
  </results_reference>
  <results_reference>
    <citation>Anshu A, Price MO, Price FW Jr. Descemet stripping automated endothelial keratoplasty for Fuchs endothelial dystrophy-influence of graft diameter on endothelial cell loss. Cornea. 2013 Jan;32(1):5-8. doi: 10.1097/ICO.0b013e318247311a.</citation>
    <PMID>22710494</PMID>
  </results_reference>
  <results_reference>
    <citation>Anshu A, Price MO, Price FW Jr. Descemet membrane endothelial keratoplasty and hybrid techniques for managing failed penetrating grafts. Cornea. 2013 Jan;32(1):1-4. doi: 10.1097/ICO.0b013e3182488888.</citation>
    <PMID>22710497</PMID>
  </results_reference>
  <results_reference>
    <citation>Anshu A, Price MO, Price FW. Descemet's stripping endothelial keratoplasty: long-term graft survival and risk factors for failure in eyes with preexisting glaucoma. Ophthalmology. 2012 Oct;119(10):1982-7. doi: 10.1016/j.ophtha.2012.04.031. Epub 2012 Jun 15.</citation>
    <PMID>22705345</PMID>
  </results_reference>
  <results_reference>
    <citation>Anshu A, Price MO, Price FW Jr. Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty. Ophthalmology. 2012 Mar;119(3):536-40. doi: 10.1016/j.ophtha.2011.09.019. Epub 2012 Jan 3.</citation>
    <PMID>22218143</PMID>
  </results_reference>
  <results_reference>
    <citation>Chaurasia S, Price MO, McKee Y, Price FW Jr. Descemet membrane endothelial keratoplasty combined with epithelial debridement and mitomycin-C application for fuchs dystrophy with preoperative subepithelial fibrosis or anterior basement membrane dystrophy. Cornea. 2014 Apr;33(4):335-9. doi: 10.1097/ICO.0000000000000078.</citation>
    <PMID>24488132</PMID>
  </results_reference>
  <results_reference>
    <citation>Chaurasia S, Price FW Jr, Gunderson L, Price MO. Descemet's membrane endothelial keratoplasty: clinical results of single versus triple procedures (combined with cataract surgery). Ophthalmology. 2014 Feb;121(2):454-8. doi: 10.1016/j.ophtha.2013.09.032. Epub 2013 Nov 16.</citation>
    <PMID>24252821</PMID>
  </results_reference>
  <results_reference>
    <citation>Feng MT, Price MO, Miller JM, Price FW Jr. Air reinjection and endothelial cell density in Descemet membrane endothelial keratoplasty: five-year follow-up. J Cataract Refract Surg. 2014 Jul;40(7):1116-21. doi: 10.1016/j.jcrs.2014.04.023.</citation>
    <PMID>24957432</PMID>
  </results_reference>
  <results_reference>
    <citation>Burkhart ZN, Feng MT, Price FW Jr, Price MO. One-year outcomes in eyes remaining phakic after Descemet membrane endothelial keratoplasty. J Cataract Refract Surg. 2014 Mar;40(3):430-4. doi: 10.1016/j.jcrs.2013.08.047. Epub 2014 Jan 11.</citation>
    <PMID>24417895</PMID>
  </results_reference>
  <results_reference>
    <citation>Schoenberg ED, Price FW Jr, Miller J, McKee Y, Price MO. Refractive outcomes of Descemet membrane endothelial keratoplasty triple procedures (combined with cataract surgery). J Cataract Refract Surg. 2015 Jun;41(6):1182-9. doi: 10.1016/j.jcrs.2014.09.042. Epub 2015 Jun 19.</citation>
    <PMID>26096520</PMID>
  </results_reference>
  <results_reference>
    <citation>Price MO, Feng MT, McKee Y, Price FW Jr. Repeat Descemet Membrane Endothelial Keratoplasty: Secondary Grafts with Early Intervention Are Comparable with Fellow-Eye Primary Grafts. Ophthalmology. 2015 Aug;122(8):1639-44. doi: 10.1016/j.ophtha.2015.04.037. Epub 2015 Jun 6.</citation>
    <PMID>26050537</PMID>
  </results_reference>
  <results_reference>
    <citation>Tenkman LR, Price FW, Price MO. Descemet membrane endothelial keratoplasty donor preparation: navigating challenges and improving efficiency. Cornea. 2014 Mar;33(3):319-25. doi: 10.1097/ICO.0000000000000045.</citation>
    <PMID>24452215</PMID>
  </results_reference>
  <results_reference>
    <citation>Price MO, Lisek M, Feng MT, Price FW Jr. Effect of Donor and Recipient Diabetes Status on Descemet Membrane Endothelial Keratoplasty Adherence and Survival. Cornea. 2017 Oct;36(10):1184-1188. doi: 10.1097/ICO.0000000000001305.</citation>
    <PMID>28749899</PMID>
  </results_reference>
  <results_reference>
    <citation>Gonzalez A, Price FW Jr, Price MO, Feng MT. Prevention and Management of Pupil Block After Descemet Membrane Endothelial Keratoplasty. Cornea. 2016 Nov;35(11):1391-1395.</citation>
    <PMID>27560030</PMID>
  </results_reference>
  <results_reference>
    <citation>Price DA, Price MO, Lopez A, Price FW Jr. Effect of Descemet Membrane Endothelial Keratoplasty on Color Vision in Patients With Fuchs Dystrophy. Cornea. 2016 Aug;35(8):1045-8. doi: 10.1097/ICO.0000000000000871.</citation>
    <PMID>27158810</PMID>
  </results_reference>
  <results_reference>
    <citation>Price MO, Calhoun P, Kollman C, Price FW Jr, Lass JH. Descemet Stripping Endothelial Keratoplasty: Ten-Year Endothelial Cell Loss Compared with Penetrating Keratoplasty. Ophthalmology. 2016 Jul;123(7):1421-7. doi: 10.1016/j.ophtha.2016.03.011. Epub 2016 Apr 20.</citation>
    <PMID>27108095</PMID>
  </results_reference>
  <results_reference>
    <citation>Price MO, Scanameo A, Feng MT, Price FW Jr. Descemet's Membrane Endothelial Keratoplasty: Risk of Immunologic Rejection Episodes after Discontinuing Topical Corticosteroids. Ophthalmology. 2016 Jun;123(6):1232-6. doi: 10.1016/j.ophtha.2016.02.001. Epub 2016 Mar 13.</citation>
    <PMID>26983976</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2008</study_first_submitted>
  <study_first_submitted_qc>November 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2008</study_first_posted>
  <last_update_submitted>January 24, 2018</last_update_submitted>
  <last_update_submitted_qc>January 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>failed penetrating keratoplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fuchs' Endothelial Dystrophy</mesh_term>
    <mesh_term>Iridocorneal Endothelial Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

